Concepedia

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

Tomás Pascual, Miguel Martín, Aranzazu Fernández-Martínez, Laia Paré, Emilio Alba, A. Rodríguez-Lescure, Giuseppe Perrone, Javier Cortés, Serafín Morales, Aňa Lluch,

Frontiers in Oncology · 2019 · 19 citations · 37 references

DOIFull text

Open access

Concepts

Abstract

In the absence of gene expression data, NOLUS can help identify non-luminal disease within HR+/HER2-negative breast cancer.

References

37

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology · 2013 · 13.2K citations · Full text

, , +17

Comprehensive molecular portraits of human breast tumours

Nature · 2012 · 12.4K citations · Full text

, , +14

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang et al. · Journal of Clinical Oncology · 2009 · 4.9K citations · Full text

, , +16

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett et al. · Journal of Clinical Oncology · 2010 · 4.3K citations · Full text

, , +14

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Journal of Clinical Oncology · 2013 · 4.1K citations · Full text

, , +14